Related Experiment Video
Updated: May 7, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Congenital heart defects in patients with deletions upstream of SOX9
Marta Sanchez-Castro1, Christopher T Gordon, Florence Petit
1INSERM, UMR1087, l'institut du thorax, Nantes, France; Université de Nantes, Nantes, France.
Abstract:
Heterozygous loss-of-function coding-sequence mutations of the transcription factor SOX9 cause campomelic dysplasia, a rare skeletal dysplasia with congenital bowing of long bones (campomelia), hypoplastic scapulae, a missing pair of ribs, pelvic, and vertebral malformations, clubbed feet, Pierre Robin sequence (PRS), facial dysmorphia, and disorders of sex development. We report here two unrelated families that include patients with isolated PRS, isolated congenital heart defect (CHD), or both anomalies. Patients from both families carried a very similar ∼1 Mb deletion upstream of SOX9. Analysis of ChIP-Seq from mouse cardiac tissue for H3K27ac, a marker of active regulatory elements, led us to identify several putative cardiac enhancers within the deleted region. One of these elements is known to interact with Nkx2.5 and Gata4, two transcription factors responsible for CHDs. Altogether, these data suggest that disruption of cardiac enhancers located upstream of SOX9 may be responsible for CHDs in humans.
Insights
Genetic deletions upstream of the SOX9 gene can cause congenital heart defects (CHDs) and Pierre Robin sequence (PRS). These deletions disrupt cardiac enhancers, impacting SOX9 gene regulation and leading to developmental anomalies.
Area of Science:
- Genetics
- Developmental Biology
- Molecular Biology
Background:
- SOX9 is a crucial transcription factor involved in skeletal development and sex determination.
- Mutations in SOX9 cause campomelic dysplasia, a severe skeletal disorder with multiple congenital anomalies.
- The genetic and regulatory mechanisms underlying isolated congenital heart defects (CHDs) and Pierre Robin sequence (PRS) are not fully understood.
Purpose of the Study:
- To investigate the genetic basis of isolated Pierre Robin sequence (PRS) and congenital heart defects (CHDs) in two unrelated families.
- To identify the specific genetic alterations responsible for these phenotypes.
- To explore the functional consequences of these alterations on SOX9 gene regulation and cardiac development.
Main Methods:
- Whole-genome sequencing to identify deletions in patients with PRS and/or CHDs.
- Comparative genomic hybridization (CGH) to confirm deletions.
- Chromatin immunoprecipitation sequencing (ChIP-Seq) using H3K27ac in mouse cardiac tissue to identify active regulatory elements.
- Bioinformatic analysis to identify cardiac enhancers within the deleted region and their potential interactions with known cardiac transcription factors.
Main Results:
- Two unrelated families presented with isolated PRS, isolated CHDs, or both anomalies.
- Patients in both families carried a similar large deletion (approximately 1 Mb) upstream of the SOX9 gene.
- Analysis revealed several putative cardiac enhancers within the deleted region, including one known to interact with cardiac transcription factors Nkx2.5 and Gata4.
Conclusions:
- Disruption of critical cardiac enhancers located upstream of SOX9 is a potential cause of CHDs in humans.
- These findings expand the phenotypic spectrum associated with SOX9 regulatory element disruption beyond campomelic dysplasia.
- This study highlights the importance of non-coding regulatory regions in human development and disease.
Related Concept Videos
Pleiotropy
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Sex-linked Disorders
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...

